Business Description
CohBar Inc
NAICS : 541714
SIC : 2835
ISIN : US19249J1097
Compare
Compare
Traded in other countries / regions
CWBR.USACOB.U.Canada IPO Date
2015-01-06Description
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria-based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drugs such as CB4209 and CB4211, SHLP-6, SHLP-2, and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operations of the group functioned through the region of the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.76 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 0.2 | |||||
| 3-Year FCF Growth Rate | -0.6 | |||||
| 3-Year Book Growth Rate | 23.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -23.94 | |||||
| 12-1 Month Momentum % | 189.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.15 | |||||
| Quick Ratio | 4.15 | |||||
| Cash Ratio | 4.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -81.54 | |||||
| ROA % | -75.5 | |||||
| ROIC % | -5099.84 | |||||
| ROC (Joel Greenblatt) % | -7024.92 | |||||
| ROCE % | -81.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PB Ratio | 21.01 | |||||
| Price-to-Tangible-Book | 20.83 | |||||
| EV-to-EBIT | -14.78 | |||||
| EV-to-EBITDA | -14.89 | |||||
| EV-to-FCF | -23.61 | |||||
| Price-to-Net-Current-Asset-Value | 20.83 | |||||
| Price-to-Net-Cash | 21.74 | |||||
| Earnings Yield (Greenblatt) % | -6.77 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CohBar Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 104.72 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 189.44 | ||
| 52-Week Range ($) | 1.5 - 7.5 | ||
| Shares Outstanding (Mil) | 39.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CohBar Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CohBar Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CohBar Inc Frequently Asked Questions
What is CohBar Inc(TSXV:COB.U)'s stock price today?
The current price of TSXV:COB.U is $5.00. The 52 week high of TSXV:COB.U is $7.50 and 52 week low is $1.50.
When is next earnings date of CohBar Inc(TSXV:COB.U)?
The next earnings date of CohBar Inc(TSXV:COB.U) is 2023-11-15 Est..
Does CohBar Inc(TSXV:COB.U) pay dividends? If so, how much?
CohBar Inc(TSXV:COB.U) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers